Our radiotherapy specialists care for more patients than any other cancer center in Ohio. More than 4,500 patients are treated with radiotherapy at our treatment facilities each year and the Taussig Cancer Institute has one of largest brachytherapy programs in the world.
"Our patients have benefited from the wide range of technologies that the Taussig Cancer Institute offers – but it is ultimately the people behind the technologies who remain important to our continued success."
Medical Economics magazine recently recognized Cleveland Clinic as a "Clinical Center of Excellence in Prostate Cancer" based on information received from key opinion leaders in various specialties, physician surveys, and self reported data.
Radiation Oncology’s multidisciplinary approach to cancer care coupled with the use of cutting edge technologies and dedication to research and education provide better outcomes and experiences for our patients.
Radiation Oncology Outcomes
Taussig Cancer Institute's superior outcomes using external beam and implant radiotherapy for prostate cancer have been internationally recognized.
Below is a sample of some of our outcomes using radiation therapy at the Taussig Cancer Institute. Please feel free to contact us with any questions or to schedule and appointment.
Breast Cancer
Overall Survival for Patients Treated with Radiation.
CC = Cleveland Clinic
Ref = Reference group data from Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute, 1983-1998, as reported in: Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer Science & Business Media; 2002:12.
Prostate Cancer
Biochemical Relapse-Free Survival for Patients with Low Risk Prostate Cancer by Treatment Type (N = 3,968): 1996-2008
| Treatment Type |
Five-Year Biochemical Relapse-Free Survival, % |
| Low-dose-rate brachytherapy (PI) |
95 |
| Radical prostatectomy (RP) |
93 |
| External beam radiotherapy (RT) |
95 |
Biochemical Relapse-Free Survival for Patients with Intermediate Risk Prostate Cancer by Treatment Type (N = 2,369): 1996-2008
| Treatment Type |
Five-Year Biochemical Relapse-Free Survival, % |
| Low-dose-rate brachytherapy (PI) |
89 |
| Radical prostatectomy (RP) |
80 |
| External beam radiotherapy (RT) |
85 |
Biochemical Relapse-Free Survival for Patients with High Risk Prostate Cancer by Treatment Type (N = 1,662): 1996-2008
| Treatment Type |
Five-Year Biochemical Relapse-Free Survival, % |
| Low-dose-rate brachytherapy (PI) |
71 |
| Radical prostatectomy (RP) |
57 |
| External beam radiotherapy (RT) |
74 |
For the complete list of Outcomes, Please visit our Quality and Patient Safety Institute Page:
